UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 19, 2012
ASHLAND INC.
(Exact name of registrant as specified in its charter)
Kentucky
(State or other jurisdiction of incorporation)
| 1-32532 | 20-0865835 | |||
| (Commission File Number) | (I.R.S. Employer Identification No.) | |||
50 E. RiverCenter Boulevard
P.O. Box 391
Covington, Kentucky 41012-0391
Registrant’s telephone number, including area code (859) 815-3333
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On September 19, 2012, Janice J. Teal, Ph.D., former Group Vice President and Chief Scientific Officer of Avon Products, Inc., was elected to serve as Director in Class III on the Board of Directors of Ashland Inc. (“Ashland”). Dr. Teal will serve on the Board’s Environmental, Health and Safety Committee and Personnel and Compensation Committee.
Pursuant to Ashland’s By-laws, the Board increased the number of directors to eleven and elected Dr. Teal to the Board.
Dr. Teal will enter into Ashland’s standard Director Indemnification Agreement.
The election of Dr. Teal to Ashland’s Board of Directors is discussed in more detail in the news release attached hereto as Exhibit 99.1, which is incorporated by reference into this Item 5.02.
| Item 9.01. | Financial Statements and Exhibits |
(d) | Exhibits | |
| 99.1 | News Release dated September 19, 2012. |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ASHLAND INC. | |
| (Registrant) | |
| September 19, 2012 | /s/ Lamar M. Chambers |
| Lamar M. Chambers | |
Senior Vice President and Chief Financial Officer |
-3-
EXHIBIT INDEX
| 99.1 | News Release dated September 19, 2012. |